CEP1612, a dipeptidyl proteasome inhibitor, induces p27WAF1and p27KIP1expression and apoptosis and inhibits the growth of the human lung adenocarcinoma A-549 in nude mice

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1280-1284

  Sun, Jiazhi ^a   Nam, Sangkil ^a   Lee, Chang Sun ^c   Li, Benyi ^a   Coppola, Domenico ^b   Hamilton, Andrew D ^c   Dou, Q Ping ^a   Sebti, Saïd M ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEP 1612; DIPEPTIDYL PROTEASOME INHIBITOR; PHTHALIMIDE DERIVATIVE; PROTEASOME INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DIPEPTIDES; FEMALE; GROWTH INHIBITORS; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; PHTHALIMIDES; PROTEASE INHIBITORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035866355     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Structure and functions of the 20S and 26S proteasome
2. Functions of the proteasome: The lysis at the end of the tunnel
3. The proteasome, a novel protease regulated by multiple mechanisms
4. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation
5. The proteasome: Paradigm of a self-compartmentalizing protease
6. Proteasome inhibitors: Valuable new tools for cell biologists
7. The ubiquitin-proteasome pathway: On protein death and cell life
8. Proteasome inhibitors as potential novel anticancer agents
9. The ubiquitin-proteasome pathway in cancer
10. Inhibition of the proteasome as a therapeutic approach
11. New inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell
12. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
13. Design and synthesis of novel protease inhibitors tripeptide α′,β′-epoxyketones as nanomolar inactivators of the proteasome
14. Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids
15. A new structural class of proteasome inhibitors that prevent NF-κ B activation
16. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes
17. Potent inhibitors of proteasome
18. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-1 antigen-processing pathway
19. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts
20. Proteasome inhibition leads to significant reduction of Bcr-Abl expression and subsequent induction of apoptosis in K562 human chronic myelogenous leukemia cells
21. Cleavage of retinoblastoma protein during apoptosis: An interleukin 1β-converting enzyme-like protease as candidate
22. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts
23. Proteasomedependent regulation of p21WAFI/CIPI expression
24. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
25. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor
26. Proteasome inhibitors: A novel class of potent and effective antitumor agents